| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| [2] |
Petrowsky H, Busuttil RW. Resection or ablation of small hepatocellular carcinoma: what is the better treatment?[J]. J Hepatol, 2008, 49(4): 502-504.
|
| [3] |
Livraghi T, Festi D, Monti F, et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors[J]. Radiology, 1986, 161(2): 309-312.
|
| [4] |
Yu YQ, Tang ZY, Zhou XD. High-power Nd: YAG laser in the treatment of liver cancer: experimental and clinical study[J]. Zhonghua Wai Ke Za Zhi, 1986, 24(3): 152-155, 188.
|
| [5] |
Zhou XD, Tang ZY, Yu YQ, et al. Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Report of 60 cases[J]. Cancer, 1988, 61(9): 1889-1892.
|
| [6] |
Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma[J]. Cancer, 1994, 74(3): 817-825.
|
| [7] |
Kainuma O, Asano T, Aoyama H, et al. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer[J]. Hepatogastroenterology, 1999, 46(26): 1071-1077.
|
| [8] |
Wu F, Chen WZ, Bai J, et al. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound[J]. Ultrasound Med Biol, 2001, 27(8): 1099-1106.
|
| [9] |
Huang K. The pilot experience of irreversible electroporation for medium-size liver cancers in the Asia[J]. J Vasc Interv Radiol, 2013, 24(759): e30.
|
| [10] |
Nishida T, Inoue K, Kawata Y, et al. Percutaneous radiofrequency ablation of lung neoplasms: A minimally invasive strategy for inoperable patients[J]. J Am Coll Surg, 2002, 195(3): 426-430.
|
| [11] |
Kim YS, Rhim H, Tae K, et al. Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience[J]. Thyroid, 2006, 16(4): 361-367.
|
| [12] |
汪伟, 刘文英. 高强度聚焦超声治疗症状性子宫肌瘤的初步临床研究[J]. 中华超声影像学杂志, 2002, 11(3): 3.
|
| [13] |
Yu J, Zhang X, Liu H, et al. Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: A propensity-matched cohort study of 1 955 patients[J]. Radiology, 2020, 294(3): 698-706.
|
| [14] |
Wu F, Wang ZB, Zhu H, et al. Feasibility of US-guided high-intensity focused ultrasound treatment in patients with advanced pancreatic cancer: initial experience[J]. Radiology, 2005, 236(3): 1034-1040.
|
| [15] |
Yu J, Han ZY, Li T, et al. Microwave ablation versus nipple sparing mastectomy for breast cancer </=5 cm: A pilot cohort study[J]. Front Oncol, 2020, 10: 546883.
|
| [16] |
Chen W, Zhu H, Zhang L, et al. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation[J]. Radiology, 2010, 255(3): 967-978.
|
| [17] |
Wang Y, Liang P, Yu X, et al. Ultrasound-guided percutaneous microwave ablation of adrenal metastasis: preliminary results[J]. Int J Hyperthermia, 2009, 25(6): 455-461.
|
| [18] |
Zhou W, Chen Y, Zhang L, et al. Percutaneous microwave ablation of metastatic lymph nodes from papillary thyroid carcinoma: preliminary results[J]. World J Surg, 2019, 43(4): 1029-1037.
|
| [19] |
Hua LX, Wu HF, Sui YG, et al. High intensity focused ultrasound combined with endocrine therapy in treating prostate cancer[J]. Zhonghua Nan Ke Xue, 2005, 11(3): 195-197.
|
| [20] |
Kim BS, Eom TI, Kang KH, et al. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism[J]. J Med Ultrason (2001), 2014, 41(2): 239-243.
|
| [21] |
Tanaka R, Kim CH, Yamada N, et al. Radiofrequency hyperthermia for malignant brain tumors: preliminary results of clinical trials[J]. Neurosurgery, 1987, 21(4): 478-483.
|
| [22] |
Yu J, Liang P, Yu X, et al. Clinical evaluation of ultrasound-guided percutaneous microwave ablation of splenic tumors[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2015, 35(3): 333-337.
|
| [23] |
Teratani T, Ishikawa T, Shiratori Y, et al. Hepatocellular carcinoma in elderly patients: beneficial therapeutic efficacy using percutaneous ethanol injection therapy[J]. Cancer, 2002, 95(4): 816-823.
|
| [24] |
Huang GT, Lee PH, Tsang YM, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: A prospective study[J]. Ann Surg, 2005, 242(1): 36-42.
|
| [25] |
Ahmed M, Brace CL, Lee FT Jr, et al. Principles of and advances in percutaneous ablation[J]. Radiology, 2011, 258(2): 351-369.
|
| [26] |
Yang B, You X, Yuan ML, et al. Transarterial ethanol ablation ccombined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus[J]. Hepat Mon, 2016, 16(8): e37584.
|
| [27] |
Zhou P, Liu X, Li R, et al. Percutaneous coagulation therapy of hepatocellular carcinoma by combining microwave coagulation therapy and ethanol injection[J]. Eur J Radiol, 2009, 71(2): 338-342.
|
| [28] |
Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma[J]. Cancer J Sci Am, 1995, 1(1): 73-81.
|
| [29] |
Shiina S, Tateishi R, Arano T, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors[J]. Am J Gastroenterol, 2012, 107(4): 569-577.
|
| [30] |
Kim YS, Lim HK, Rhim H, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors[J]. J Hepatol, 2013, 58(1): 89-97.
|
| [31] |
Lee MW, Kang D, Lim HK, et al. Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival[J]. Eur Radiol, 2020, 30(4): 2391-2400.
|
| [32] |
Koda M, Murawaki Y, Hirooka Y, et al. Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients[J]. Hepatol Res, 2012, 42(11): 1058-1064.
|
| [33] |
Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria[J]. Ann Surg, 2010, 252(6): 903-912.
|
| [34] |
Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma[J]. Ann Surg, 2006, 243(3): 321-328.
|
| [35] |
Fang Y, Chen W, Liang X, et al. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2014, 29(1): 193-200.
|
| [36] |
Ng KKC, Chok KSH, Chan ACY, et al. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma[J]. Br J Surg, 2017, 104(13): 1775-1784.
|
| [37] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 182-236.
|
| [38] |
Dong BW, Liang P, Yu XL, et al. Sonographically guided microwave coagulation treatment of liver cancer: An experimental and clinical study[J]. AJR Am J Roentgenol, 1998, 171(2): 449-454.
|
| [39] |
Liang P, Yu J, Yu XL, et al. Percutaneous cooled-tip microwave ablation under ultrasound guidance for primary liver cancer: A multicentre analysis of 1 363 treatment-naive lesions in 1 007 patients in China[J]. Gut, 2012, 61(7): 1100-1101.
|
| [40] |
Lu MD, Xu HX, Xie XY, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: A retrospective comparative study[J]. J Gastroenterol, 2005, 40(11): 1054-1060.
|
| [41] |
Dong B, Liang P, Yu X, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients[J]. AJR Am J Roentgenol, 2003, 180(6): 1547-1555.
|
| [42] |
Ding J, Jing X, Liu J, et al. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma[J]. Eur J Radiol, 2013, 82(9): 1379-1384.
|
| [43] |
Ryu T, Takami Y, Wada Y, et al. Operative microwave ablation for hepatocellular carcinoma within 3 cm and 3 nodules: experience in 559 patients[J]. J Gastrointest Surg, 2022, 26(3): 615-622.
|
| [44] |
Yu J, Chen Z, Han Z, et al. Period-dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: A 12-year real-world multicentric experience[J]. Liver Cancer, 2022.
|
| [45] |
Chong CCN, Lee KF, Chu CM, et al. Microwave ablation provides better survival than liver resection for hepatocellular carcinoma in patients with borderline liver function: application of ALBI score to patient selection[J]. HPB (Oxford), 2018, 20(6): 546-554.
|
| [46] |
Liu W, Zou R, Wang C, et al. Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: A propensity-score analysis[J]. Ther Adv Med Oncol, 2019, 11: 1758835919874652.
|
| [47] |
Sun Q, Shi J, Ren C, et al. Survival analysis following microwave ablation or surgical resection in patients with hepatocellular carcinoma conforming to the Milan criteria[J]. Oncol Lett, 2020, 19(6): 4066-4076.
|
| [48] |
Zheng H, Xu C, Wang X, et al. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm[J]. Int J Hyperthermia, 2020, 37(1): 1345-1353.
|
| [49] |
Wang Z, Liu M, Zhang DZ, et al. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC[J]. Hepatology, 2022.
|
| [50] |
Thomson KR, Cheung W, Ellis SJ, et al. Investigation of the safety of irreversible electroporation in humans[J]. J Vasc Interv Radiol, 2011, 22(5): 611-621.
|
| [51] |
Du S, Yang JZ, Chen J, et al. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: A multiple centers retrospective cohort study with propensity score matching[J]. PloS One, 2020, 15(1): e0227242.
|
| [52] |
Han X, Ni JY, Li SL, et al. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: A retrospective controlled study[J]. Abdom Radiol (NY), 2021, 46(8): 3758-3771.
|
| [53] |
Lee KF, Wong J, Hui JW, et al. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study[J]. Asian J Surg, 2017, 40(4): 301-308.
|
| [54] |
Ohmoto K, Yoshioka N, Tomiyama Y, et al. Radiofrequency ablation versus percutaneous microwave coagulation therapy for small hepatocellular carcinomas: A retrospective comparative study[J]. Hepatogastroenterology, 2007, 54(76): 985-989.
|
| [55] |
Zheng H, Liu K, Yang Y, et al. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: A propensity score-matched study[J]. Eur Radiol, 2022.
|
| [56] |
Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: A phase Ⅲ randomised controlled trial[J]. Gut, 2017, 66(6): 1172-1173.
|
| [57] |
Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma[J]. Gastroenterology, 2005, 129(1): 122-130.
|
| [58] |
Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less[J]. Gut, 2005, 54(8): 1151-1156.
|
| [59] |
Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm[J]. Gastroenterology, 2004, 127(6): 1714-1723.
|
| [60] |
Kuroda H, Nagasawa T, Fujiwara Y, et al. Comparing the safety and efficacy of microwave ablation using thermosphere TM technology versus radiofrequency ablation for hepatocellular carcinoma: A propensity score-matched analysis[J]. Cancers (Basel), 2021, 13(6): 1295.
|
| [61] |
Lin YM, Paolucci I, Brock KK, et al. Image-guided ablation for colorectal liver metastasis: principles, current evidence, and the path forward[J]. Cancers (Basel), 2021, 13(16): 3926.
|
| [62] |
梁萍, 董宝玮, 于晓玲, 等. 超声引导经皮微波消融治疗肝转移癌疗效评价[J].中华医学杂志, 2006, 86(12): 806-810.
|
| [63] |
Tago T, Katsumata K, Udou R, et al. Significance of radiofrequency ablation for unresectable colorectal cancer with liver metastases[J]. Anticancer Res, 2021, 41(11): 5539-5547.
|
| [64] |
Tsilimigras DI, Brodt P, Clavien PA, et al. Liver metastases[J]. Nat Rev Dis Primers, 2021, 7(1): 27.
|
| [65] |
Dupuy DE, Zagoria RJ, Akerley W, et al. Percutaneous radiofrequency ablation of malignancies in the lung[J]. AJR Am J Roentgenol, 2000, 174(1): 57-59.
|
| [66] |
Kodama H, Yamakado K, Hasegawa T, et al. Radiofrequency ablation using a multiple-electrode switching system for lung tumors with 2.0-5.0-cm maximum diameter: phase Ⅱ clinical study[J]. Radiology, 2015, 277(3): 895-902.
|
| [67] |
Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: A multicenter study in Japan[J]. J Vasc Interv Radiol, 2007, 18(3): 393-398.
|
| [68] |
Lu Q, Cao W, Huang L, et al. CT-guided percutaneous microwave ablation of pulmonary malignancies: results in 69 cases[J]. World J Surg Oncol, 2012, 10: 80.
|
| [69] |
Gobara H, Arai Y, Kobayashi T, et al. Percutaneous radiofrequency ablation for patients with malignant lung tumors: A phase Ⅱ prospective multicenter study (JIVROSG-0702)[J]. Jpn J Radiol, 2016, 34(8): 556-563.
|
| [70] |
Li X, Wang J, Li W, et al. Percutaneous CT-guided radiofrequency ablation for unresectable hepatocellular carcinoma pulmonary metastases[J]. Int J Hyperthermia, 2012, 28(8): 721-728.
|
| [71] |
Nomori H, Yamazaki I, Shiraishi A, et al. Cryoablation for T1N0M0 non-small cell lung cancer using liquid nitrogen[J]. Eur J Radiol, 2020, 133: 109334.
|
| [72] |
Feng B, Liang P, Cheng Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies[J]. Eur J Endocrinol, 2012, 166(6): 1031-1037.
|
| [73] |
Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: A 3-year follow-up study[J]. J Cancer Res Clin Oncol, 2018, 144(4): 771-779.
|
| [74] |
Turtulici G, Orlandi D, Corazza A, et al. Percutaneous radiofrequency ablation of benign thyroid nodules assisted by a virtual needle tracking system[J]. Ultrasound Med Biol, 2014, 40(7): 1447-1452.
|
| [75] |
Hong MJ, Baek JH, Choi YJ, et al. Radiofrequency ablation is a thyroid function-preserving treatment for patients with bilateral benign thyroid nodules[J]. J Vasc Interv Radiol, 2015, 26(1): 55-61.
|
| [76] |
Sung JY, Baek JH, Kim KS, et al. Single-session treatment of benign cystic thyroid nodules with ethanol versus radiofrequency ablation: A prospective randomized study[J]. Radiology, 2013, 269(1): 293-300.
|
| [77] |
Kim YJ, Baek JH, Ha EJ, et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors[J]. Eur Radiol, 2012, 22(7): 1573-1578.
|
| [78] |
Peng K, Zhou P, Liu W. Long-term efficacy of ultrasound-guided percutaneous laser ablation for low-risk papillary thyroid microcarcinoma: A 5-year follow-up study[J]. Biomed Res Int, 2021, 2021: 6616826.
|
| [79] |
Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: A prospective study[J]. Thyroid, 2016, 26(11): 1581-1587.
|
| [80] |
Huh JY, Baek JH, Choi H, et al. Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session--prospective randomized study[J]. Radiology, 2012, 263(3): 909-916.
|
| [81] |
Kim C, Lee JH, Choi YJ, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers[J]. Eur Radiol, 2017, 27(8): 3128-3137.
|
| [82] |
Lim HK, Baek JH, Lee JH, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer[J]. Eur Radiol, 2015, 25(1): 163-170.
|
| [83] |
Baek JH, Ha EJ, Choi YJ, et al. Radiofrequency versus ethanol ablation for treating predominantly cystic thyroid nodules: A randomized clinical trial[J]. Korean J Radiol, 2015, 16(6): 1332-1340.
|
| [84] |
Cao XJ, Wang SR, Che Y, et al. Efficacy and safety of thermal ablation for treatment of solitary T1N0M0 papillary thyroid carcinoma: A multicenter retrospective study[J]. Radiology, 2021, 300(1): 209-216.
|
| [85] |
Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up[J]. Thyroid, 2020, 30(3): 408-417.
|
| [86] |
Scarperi S, Pontrelli G, Campana C, et al. Laparoscopic radiofrequency thermal ablation for uterine adenomyosis[J]. JSLS, 2015, 19(4): e2015.
|
| [87] |
张晶, 董宝玮, 冯蕾, 等. 超声引导经皮穿刺微波消融治疗子宫肌瘤1例[J]. 中华超声影像学杂志, 2008, 17(4): 326.
|
| [88] |
Liu H, Zhang J, Han ZY, et al. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: A multicentre study in China[J]. Int J Hyperthermia, 2016, 32(8): 876-880.
|
| [89] |
Hai N, Hou Q, Ding X, et al. Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis[J]. Br J Radiol, 2017, 90(1069): 20160119.
|
| [90] |
Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: An IDEAL prospective exploration study[J]. BJOG, 2018, 125(3): 354-364.
|
| [91] |
Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: A retrospective study[J]. BJOG, 2020, 127(11): 1422-1428.
|
| [92] |
Zegel HG, Holland GA, Jennings SB, et al. Intraoperative ultrasonographically guided cryoablation of renal masses: initial experience[J]. J Ultrasound Med, 1998, 17(9): 571-576.
|
| [93] |
Ukimura O, Kawauchi A, Fujito A, et al. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk[J]. Int J Urol, 2004, 11(12): 1051-1057.
|
| [94] |
Liang P, Wang Y, Zhang D, et al. Ultrasound guided percutaneous microwave ablation for small renal cancer: initial experience[J]. J Urol, 2008, 180(3): 844-848.
|
| [95] |
Yu J, Wang H, Cheng ZG, et al. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?[J]. Eur Radiol, 2022, 32(1): 89-100.
|
| [96] |
Chang X, Liu T, Zhang F, et al. Radiofrequency ablation versus partial nephrectomy for clinical T1a renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis[J]. J Endourol, 2015, 29(5): 518-525.
|
| [97] |
Zhang F, Chang X, Liu T, et al. Prognostic factors for long-term survival in patients with renal-cell carcinoma after radiofrequency ablation[J]. J Endourol, 2016, 30(1): 37-42.
|
| [98] |
Liu N, Huang D, Cheng X, et al. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype[J]. Urol Oncol, 2017, 35(8): e531-e536.
|
| [99] |
Yu J, Liang P, Yu XL, et al. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results[J]. Radiology, 2014, 270(3): 880-887.
|
| [100] |
Takaki H, Yamakado K, Soga N, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma[J]. Jpn J Radiol, 2010, 28(6): 460-468.
|
| [101] |
Takaki H, Soga N, Kanda H, et al. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma[J]. Radiology, 2014, 270(1): 292-299.
|
| [102] |
Tinguely P, Paolucci I, Ruiter SJS, et al. Stereotactic and robotic minimally invasive thermal ablation of malignant liver tumors: A systematic review and Meta-analysis[J]. Front Oncol, 2021, 11: 713685.
|
| [103] |
Ren C, Liu SR, Wu WB, et al. Experimental and preliminary clinical study of real-time registration in liver tumors during respiratory motion based on a multimodality image navigation system[J]. Technol Cancer Res Treat, 2019, 18: 1533033819857767.
|
| [104] |
Minami Y, Minami T, Takita M, et al. Radiofrequency ablation for hepatocellular carcinoma: clinical value of ultrasound-ultrasound overlay fusion for optimal ablation and local controllability[J]. Hepatol Res, 2020, 50(1): 67-74.
|
| [105] |
Ju JX, Zeng QJ, Xu EJ, et al. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound[J]. Int J Hyperthermia, 2019, 36(1): 785-793.
|
| [106] |
Li K, Su Z, Xu E, et al. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients[J]. BMC Cancer, 2017, 17(1): 61.
|
| [107] |
Numata K, Fukuda H, Morimoto M, et al. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma[J]. Eur J Radiol, 2012, 81(10): 2746-2753.
|
| [108] |
Lee JY, Choi BI, Chung YE, et al. Clinical value of CT/MR-US fusion imaging for radiofrequency ablation of hepatic nodules[J]. Eur J Radiol, 2012, 81(9): 2281-2289.
|
| [109] |
Song KD, Lee MW, Rhim H, et al. Percutaneous US/MRI fusion-guided radiofrequency ablation for recurrent subcentimeter hepatocellular carcinoma: technical feasibility and therapeutic outcomes[J]. Radiology, 2018, 288(3): 878-886.
|
| [110] |
Liu FY, Yu XL, Liang P, et al. Microwave ablation assisted by a real-time virtual navigation system for hepatocellular carcinoma undetectable by conventional ultrasonography[J]. Eur J Radiol, 2012, 81(7): 1455-1459.
|
| [111] |
Xu E, Long Y, Li K, et al. Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors[J]. Int J Hyperthermia, 2019, 35(1): 159-167.
|
| [112] |
Matsuki Y, Matono T, Koda M, et al. Preablation three-dimensional ultrasonography can predict therapeutic effect and local tumor progression after radiofrequency ablation for hepatocellular carcinoma[J]. Eur J Radiol, 2020, 133: 109358.
|
| [113] |
Xu C, Zheng H, Shi T, et al. A prediction model of major complications after radiofrequency ablation for recurrent hepatocellular carcinoma patients[J]. Eur J Radiol, 2021, 140: 109635.
|
| [114] |
Qi C, Li S, Zhang L. Development and validation of a clinicopathological-based nomogram to predict the survival outcome of patients with recurrent hepatocellular carcinoma after hepatectomy who underwent microwave ablation[J]. Cancer Manag Res, 2020, 12: 7589-7600.
|
| [115] |
Zhang G, Yang H, Zhu X, et al. A CT-based radiomics nomogram to predict complete ablation of pulmonary malignancy: A multicenter study[J]. Front Oncol, 2022, 12: 841678.
|
| [116] |
Liu F, Liu D, Wang K, et al. Deep learning radiomics based on contrast-enhanced ultrasound might optimize curative treatments for very-early or early-stage hepatocellular carcinoma patients[J]. Liver Cancer, 2020, 9(4): 397-413.
|
| [117] |
Ma QP, He XL, Li K, et al. Dynamic contrast-enhanced ultrasound radiomics for hepatocellular carcinoma recurrence prediction after thermal ablation[J]. Mol Imaging Biol, 2021, 23(4): 572-585.
|
| [118] |
Ding W, Wang Z, Liu F, et al. A hybrid machine learning model based on semantic information can optimize treatment decision for naïve single 3-5 cm HCC patients[J]. Liver Cancer, 2022.
|
| [119] |
Dong BW, Zhang J, Liang P, et al. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma[J]. Int J Hyperthermia, 2003, 19(2): 119-133.
|
| [120] |
Shi L, Wang J, Ding N, et al. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy[J]. Nat Commun, 2019, 10(1): 5421.
|
| [121] |
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy[J]. Nat Rev Cancer, 2014, 14(3): 199-208.
|
| [122] |
Weng DS, Zhou J, Zhou QM, et al. Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas[J]. J Immunother, 2008, 31(1): 63-71.
|
| [123] |
Ma H, Zhang Y, Wang Q, et al. Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation[J]. Cancer Biol Ther, 2010, 9(11): 903-907.
|
| [124] |
Liang S, Niu L, Xu K, et al. Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer[J]. Mol Immunol, 2017, 92: 45-53.
|
| [125] |
Lin M, Liang S, Wang X, et al. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage Ⅲ/Ⅳ) pancreatic cancer: A promising treatment[J]. J Cancer Res Clin Oncol, 2017, 143(12): 2607-2618.
|
| [126] |
Lin M, Liang SZ, Wang XH, et al. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer[J]. Immunol Res, 2017, 65(4): 880-887.
|
| [127] |
Yang Y, Qin Z, Du D, et al. Safety and short-term efficacy of irreversible electroporation and allogenic natural killer cell immunotherapy combination in the treatment of patients with unresectable primary liver cancer[J]. Cardiovasc Intervent Radiol, 2019, 42(1): 48-59.
|
| [128] |
Lin M, Xu K, Liang S, et al. Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancer[J]. Immunol Lett, 2017, 184: 98-104.
|
| [129] |
Wang X, Liu G, Chen S, et al. Combination therapy with PD-1 blockade and radiofrequency ablation for recurrent hepatocellular carcinoma: A propensity score matching analysis[J]. Int J Hyperthermia, 2021, 38(1): 1519-1528.
|
| [130] |
Ren XL, Zhou XD, Yan RL, et al. Sonographically guided extracorporeal ablation of uterine fibroids with high-intensity focused ultrasound: midterm results[J]. J Ultrasound Med, 2009, 28(1): 100-103.
|
| [131] |
Wang W, Wang Y, Wang T, et al. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids[J]. Eur Radiol, 2012, 22(11): 2553-2558.
|
| [132] |
Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids[J]. Int J Hyperthermia, 2020, 37(1): 1046-1051.
|
| [133] |
Lee JS, Hong GY, Lee KH, et al. Safety and efficacy of ultrasound-guided high-intensity focused ultrasound treatment for uterine fibroids and adenomyosis[J]. Ultrasound Med Biol, 2019, 45(12): 3214-3221.
|